China's Shengtai Q4 net profit up 97 pct on strong pharmaceutical sales
Written by Thomson Financial
Feb 15, 2008 at 08:47 PM
Feb. 15, 2008 (Thomson Financial delivered by Newstex) --
BEIJING (XFN-ASIA) - Shengtai Pharmaceutical Inc (OTCBB:SGTI) (OTC Bulletin Board: SGTI) said fourth quarter net profit rose 97 pct year-on-year to 3.1 mln usd on robust sales of pharmaceutical grade glucose products.
Shengtai, based in the eastern Chinese province of Shandong, said revenue in the October-December period rose 102.7 pct to 25.0 mln usd.
